What is the purpose of antibiotic therapy in treating clients with peptic ulcer disease (PUD)?

Peptic ulcer disease involves mucosal erosion within the stomach or duodenum, predominantly driven by Helicobacter pylori infection or NSAID use. This gram-negative bacterium colonizes the gastric antrum, secreting urease to neutralize stomach acid and inducing chronic inflammation. Eradication of the pathogen is essential to promote definitive mucosal healing and prevent ulcer recurrence. A. Antibiotics eliminate a microorganism called helicobacter pylori: Specific antibiotic regimens, often including clarithromycin or amoxicillin, target the bacterial cell wall or protein synthesis. Eradicating this causative pathogen resolves the underlying inflammatory stimulus that prevents the gastric lining from repairing itself. This is the curative cornerstone of therapy. B. Antibiotics add a protective coating over the ulcerated mucosa: This function describes cytoprotective agents like sucralfate rather than antimicrobial drugs. Antibiotics do not possess the biophysical properties required to form a physical barrier against gastric acid. Their role is purely biochemical and bactericidal in nature. C. Antibiotics prevent secondary gastrointestinal infections: PUD treatment focuses on a primary infection rather than prophylaxis against opportunistic organisms. Using antibiotics to prevent hypothetical infections would be clinically inappropriate and contribute to antimicrobial resistance. The therapy is targeted at a specific, identified pathogen. D. Antibiotics heal the irritated mucous membrane of the stomach: While antibiotics allow healing to occur by removing the bacteria, they do not directly stimulate tissue regeneration. Healing is a physiological process mediated by the body or assisted by proton pump inhibitors. Antibiotics simply eliminate the obstacle to recovery.